LONDON (Reuters) – There is no evidence that the Astrazeneca vaccine does not prevent death or serious illness, and South Africa has only temporarily suspended its use of the vaccine, a health minister said. young British Monday.
South Africa will stop using AstraZeneca COVID-19 bullet in their vaccination program after data showed it provided little protection against moderate-to-severe infection caused by major coronavirus differentiation of the country.
“There is no evidence that this vaccine is effective in preventing hospitalization and serious illness and death, and that is ultimately what we are seeking with these vaccines. today, ”said Edward Argar of Britain to Sky.
“The strongest rays in this country are not the South African snoring, there are a small number of cases, the main lines here are the historical one we got, and then the Kent strain, which is the vaccine this is very effective. . ”
Israel is currently far ahead of the rest of the world in vaccines per capita, followed by the United Arab Emirates, the United Kingdom, Bahrain, the United States and then Spain, Italy. and Germany.
The United Kingdom, which has the fifth worst official death tax in the world, has vaccinated 12.014 million people with the first dose. About half a million people have received a second dose.
While thousands of individual mutations have emerged as the virus progresses with replication and evolves to new mutations, only a small minority are likely to be significant or altering the virus in a valuable way, according to the British Medical Journal.
Coronavirus changes that are currently of concern to scientists and public health experts include the so-called British, South African and Brazilian variants, which appear to be more contagious than others.
Reciting with Guy Faulconbridge and Kate Holton; edited by Michael Holden